论文部分内容阅读
米托蒽醌（Mitoxantorne，Mx）应用于急性白血病的治疗，为难治、复发病例的再缓解提供了可能性。我们于1992年8月至1993年6月以Mx联合化疗治疗难治、复发及巩固强化患者16例（次），现将结果报道如下。1对象与方法本组共16例（次），均为男性，年龄21～56岁。分为难治、复发组
Mitoxantorne (Mx) is used in the treatment of acute leukemia, providing possibilities for the remission of refractory and recurrent cases. From August 1992 to June 1993, we treated 16 cases (times) of refractory, recurrent, and consolidation-enhancing patients with Mx combined chemotherapy. The results are reported below. 1 Subjects and Methods There were 16 cases (times) in this group, all male, aged 21 to 56 years old. Divided into refractory and relapsed groups